Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters

PLoS Pathog. 2024 Jan 10;20(1):e1011805. doi: 10.1371/journal.ppat.1011805. eCollection 2024 Jan.

Abstract

Hybrid immunity (vaccination + natural infection) to SARS-CoV-2 provides superior protection to re-infection. We performed immune profiling studies during breakthrough infections in mRNA-vaccinated hamsters to evaluate hybrid immunity induction. The mRNA vaccine, BNT162b2, was dosed to induce binding antibody titers against ancestral spike, but inefficient serum virus neutralization of ancestral SARS-CoV-2 or variants of concern (VoCs). Vaccination reduced morbidity and controlled lung virus titers for ancestral virus and Alpha but allowed breakthrough infections in Beta, Delta and Mu-challenged hamsters. Vaccination primed for T cell responses that were boosted by infection. Infection back-boosted neutralizing antibody responses against ancestral virus and VoCs. Hybrid immunity resulted in more cross-reactive sera, reflected by smaller antigenic cartography distances. Transcriptomics post-infection reflects both vaccination status and disease course and suggests a role for interstitial macrophages in vaccine-mediated protection. Therefore, protection by vaccination, even in the absence of high titers of neutralizing antibodies in the serum, correlates with recall of broadly reactive B- and T-cell responses.

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • BNT162 Vaccine
  • Breakthrough Infections
  • COVID-19* / prevention & control
  • Cricetinae
  • Humans
  • Immunity
  • Mesocricetus
  • Postoperative Complications
  • RNA, Messenger / genetics
  • SARS-CoV-2*
  • Vaccination

Substances

  • BNT162 Vaccine
  • Antibodies, Neutralizing
  • RNA, Messenger
  • Antibodies, Viral

Supplementary concepts

  • SARS-CoV-2 variants